- Home
- ADC vs ELAN Comparison
ADC vs ELAN Comparison
Compare ADC & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADC
- ELAN
- Stock Information
- Founded
- ADC 1971
- ELAN 1954
- Country
- ADC United States
- ELAN United States
- Employees
- ADC N/A
- ELAN N/A
- Industry
- ADC Real Estate Investment Trusts
- ELAN Biotechnology: Pharmaceutical Preparations
- Sector
- ADC Real Estate
- ELAN Health Care
- Exchange
- ADC Nasdaq
- ELAN Nasdaq
- Market Cap
- ADC 8.0B
- ELAN 7.2B
- IPO Year
- ADC 1994
- ELAN 2018
- Fundamental
- Price
- ADC $72.07
- ELAN $18.61
- Analyst Decision
- ADC Buy
- ELAN Buy
- Analyst Count
- ADC 13
- ELAN 7
- Target Price
- ADC $80.88
- ELAN $17.33
- AVG Volume (30 Days)
- ADC 915.9K
- ELAN 10.2M
- Earning Date
- ADC 10-21-2025
- ELAN 11-06-2025
- Dividend Yield
- ADC 4.21%
- ELAN N/A
- EPS Growth
- ADC N/A
- ELAN N/A
- EPS
- ADC 1.68
- ELAN 0.88
- Revenue
- ADC $659,753,000.00
- ELAN $4,484,000,000.00
- Revenue This Year
- ADC $15.43
- ELAN $5.65
- Revenue Next Year
- ADC $10.59
- ELAN $4.97
- P/E Ratio
- ADC $43.32
- ELAN $21.29
- Revenue Growth
- ADC 13.16
- ELAN N/A
- 52 Week Low
- ADC $67.58
- ELAN $8.02
- 52 Week High
- ADC $79.65
- ELAN $19.08
- Technical
- Relative Strength Index (RSI)
- ADC 51.51
- ELAN 52.90
- Support Level
- ADC N/A
- ELAN N/A
- Resistance Level
- ADC $74.08
- ELAN $19.08
- Average True Range (ATR)
- ADC 0.86
- ELAN 0.50
- MACD
- ADC -2.65
- ELAN -0.75
- Stochastic Oscillator
- ADC 97.25
- ELAN 97.67
About ADC Agree Realty Corporation
Agree Realty Corporation operates as a fully integrated real estate investment trust mainly focused on the ownership, acquisition, development and management of retail properties net leased to industry-tenants. The Company is mainly in the business of acquiring, developing and managing retail real estate. Some of its properties in the portfolio include Walmart, 7-Eleven, Wawa, Gerber Collision and others.
About ELAN Elanco Animal Health Incorporated
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.